ExoLab Italy Secures €5 Million in Series A Funding
Deal News | Feb 18, 2025 | CDP Venture Capital
ExoLab Italy has successfully closed a €5 million Series A financing round, attracting investment to support its international expansion. The startup, which focuses on the innovative use of plant-derived exosomes in product development, received backing from a consortium of unidentified investors, with significant involvement from CDP Venture Capital. This funding marks an important phase in ExoLab's growth strategy, enabling it to expand its market reach beyond Italy.
Sectors
- Biotechnology
- Venture Capital
Geography
- Italy – ExoLab Italy is based in Italy, with CDP Venture Capital also being an Italian entity.
Industry
- Biotechnology – ExoLab Italy operates in the biotechnology industry by developing products based on plant-derived exosomes.
- Venture Capital – CDP Venture Capital's investment in ExoLab Italy is a typical activity within the venture capital sector.
Financials
- €5 million – The total amount raised by ExoLab Italy in its Series A funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ExoLab Italy | Target company | Company | A startup focusing on products developed from plant-derived exosomes. |
| CDP Venture Capital | Investor | Company | A venture capital firm that invested in ExoLab Italy's Series A funding round. |